WO2004065938A3 - Human osteoporosis gene - Google Patents
Human osteoporosis gene Download PDFInfo
- Publication number
- WO2004065938A3 WO2004065938A3 PCT/US2004/000990 US2004000990W WO2004065938A3 WO 2004065938 A3 WO2004065938 A3 WO 2004065938A3 US 2004000990 W US2004000990 W US 2004000990W WO 2004065938 A3 WO2004065938 A3 WO 2004065938A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- osteoporosis
- gene
- human osteoporosis
- human
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002512239A CA2512239A1 (en) | 2003-01-16 | 2004-01-15 | Human osteoporosis gene |
EP04702489A EP1585837A2 (en) | 2003-01-16 | 2004-01-15 | Human osteoporosis gene |
JP2006500965A JP2006515992A (en) | 2003-01-16 | 2004-01-15 | Human osteoporosis gene |
US11/185,033 US20060057612A1 (en) | 2000-09-14 | 2005-07-18 | Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/661,887 US6630304B1 (en) | 2000-09-14 | 2000-09-14 | Human osteoporosis gene |
PCT/IB2001/001667 WO2002022871A2 (en) | 2000-09-14 | 2001-09-12 | Polymorphic bone morphogenetic protein 2 |
US09/952,360 US20020072066A1 (en) | 2000-09-14 | 2001-09-13 | Human osteoporosis gene |
US10/346,723 US20030176344A1 (en) | 2000-09-14 | 2003-01-16 | Human osteoporosis gene |
US10/346,723 | 2003-01-16 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/185,033 Continuation-In-Part US20060057612A1 (en) | 2000-09-14 | 2005-07-18 | Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004065938A2 WO2004065938A2 (en) | 2004-08-05 |
WO2004065938A3 true WO2004065938A3 (en) | 2004-10-28 |
Family
ID=56290520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/000990 WO2004065938A2 (en) | 2000-09-14 | 2004-01-15 | Human osteoporosis gene |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004065938A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004065939A2 (en) * | 2003-01-16 | 2004-08-05 | Decode Genetics Ehf. | Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
WO2010073266A1 (en) * | 2008-12-23 | 2010-07-01 | Decode Genetics Ehf | Sequence variants predictive of risk of kidney stones and bone mineral density |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002022871A2 (en) * | 2000-09-14 | 2002-03-21 | Decode Genetics Ehf | Polymorphic bone morphogenetic protein 2 |
-
2004
- 2004-01-15 WO PCT/US2004/000990 patent/WO2004065938A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002022871A2 (en) * | 2000-09-14 | 2002-03-21 | Decode Genetics Ehf | Polymorphic bone morphogenetic protein 2 |
Also Published As
Publication number | Publication date |
---|---|
WO2004065938A2 (en) | 2004-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004028341A3 (en) | Susceptibility gene for human stroke; methods of treatment | |
WO2002074992A3 (en) | Phosphodiesterase 4d genes related to human stroke | |
AU3997300A (en) | Gene sequence variations with utility in determining the treatment of disease | |
WO2004048526A3 (en) | MODULATION OF HIF1α AND HIF2α EXPRESSION | |
WO2003038123A3 (en) | Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene | |
WO2006063704A3 (en) | Single nucleotide polymorphism (snp) associated to type ii diabetes | |
AU2001296511A1 (en) | Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents | |
WO1998008974A3 (en) | Catalytic nucleic acid and its medical use | |
WO2001092308A3 (en) | Cystine-knot polypeptides: cloaked-2 molecules and uses thereof | |
WO2004055162A3 (en) | Modulation of endothelial lipase expression | |
WO2002022871A3 (en) | Polymorphic bone morphogenetic protein 2 | |
WO1999051727A3 (en) | Human nucleic acid sequences of normal ovary tissue | |
WO2000053776A3 (en) | Human kallikrein-like genes | |
WO2004048522A3 (en) | Modulation of huntingtin interacting protein 2 expression | |
WO2006063703A3 (en) | Single nucleotide polymorphism (snp) associated to type ii diabetes | |
AU3717600A (en) | Methods and reagents for decreasing clinical reaction to allergy | |
WO2004065938A3 (en) | Human osteoporosis gene | |
WO2004043394A3 (en) | Modulation of huntingtin interacting protein 1 expression | |
HK1042523A1 (en) | Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders | |
WO2004052309A3 (en) | Modulation of stat 6 expression | |
WO2003025010A3 (en) | Human delta-n p73 molecules and uses thereof | |
WO2003064471A3 (en) | Gene for peripheral arterial occlusive disease | |
AU1774299A (en) | Polymorphisms within the rsk-3 gene related to cancer and methods of diagnosis, prognosis, and treatment | |
WO2003062469A3 (en) | Gene matn3 or matrilin-3 linked to osteoarthritis treatment | |
WO2004047741A3 (en) | Modulation of iap-like expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2512239 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006500965 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11185033 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004702489 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004702489 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11185033 Country of ref document: US |